Balyasny Asset Management
SKINW

Balyasny Asset Management’s The Beauty Health Company Warrant expiring 5/4/2026 SKINW Stock Holding History

Balyasny Asset Management’s Portfolio SKINW Stock Details SKINW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-200,000
Closed -$416K – 2604
2021
Q1 		$416K Hold
200,000
– – ﹤0.01% 1445
2020
Q4 		$529K Buy
+200,000
New +$447K ﹤0.01% 1120

Other funds holding SKINW

SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return

Balyasny Asset Management's SKINW Position: Q2 2021 in Review

Balyasny Asset Management sold out of The Beauty Health Company Warrant expiring 5/4/2026 (SKINW) in Q2 2021, closing a stake of 200,000 shares — an estimated $416K sold.

Balyasny Asset Management first reported a position in SKINW in Q4 2020 and held it in 2 quarters. The position peaked at $529K in Q4 2020. 32 funds tracked by Wall St. Rank hold SKINW as of Q2 2021.

  • Balyasny Asset Management reported no remaining The Beauty Health Company Warrant expiring 5/4/2026 position as of Q2 2021 after selling out during the quarter.
  • Balyasny Asset Management sold 200,000 The Beauty Health Company Warrant expiring 5/4/2026 shares in Q2 2021, an estimated $416K.
  • Balyasny Asset Management first reported a position in The Beauty Health Company Warrant expiring 5/4/2026 in Q4 2020 and held it in 2 quarters.
  • Balyasny Asset Management's The Beauty Health Company Warrant expiring 5/4/2026 position peaked at $529K in Q4 2020.
  • 32 funds tracked by Wall St. Rank held The Beauty Health Company Warrant expiring 5/4/2026 as of Q2 2021.

Based on Balyasny Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.